Integrating Behavioral Therapy in the Management of Temporomandibular Disorders: A Comprehensive Evaluation Using DC/TMD Axis II Criteria

NCT ID: NCT06774196

Last Updated: 2025-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-05

Study Completion Date

2025-03-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the efficacy of behavioral therapy, including Cognitive Behavioral Therapy (CBT), relaxation techniques, and biofeedback, in managing Temporomandibular Disorders (TMD). It aims to address both the physical and psychological aspects of TMD, focusing on pain reduction, improved jaw function, and alleviating psychological distress such as anxiety and depression. Participants are randomized into two groups: an intervention group receiving behavioral therapy and a control group receiving standard care. Outcomes will be assessed using validated tools to measure pain intensity, jaw function, and psychological well-being at baseline, post-treatment, and at a 6-month follow-up. This research seeks to establish the role of behavioral therapy as a key component in the comprehensive management of TMD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Temporomandibular Joint Disorders Chronic Pain Anxiety Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Behavioral Therapy Group

Participants receiving behavioral therapy (Cognitive Behavioral Therapy, relaxation techniques, and biofeedback).

Group Type EXPERIMENTAL

Behavioral Therapy Group

Intervention Type BEHAVIORAL

Includes Cognitive Behavioral Therapy (CBT), relaxation techniques, and biofeedback.

Standard Care Group

Participants will receive standard care, consisting of pharmacological treatment (e.g., NSAIDs, muscle relaxants) and physical therapy.

Group Type ACTIVE_COMPARATOR

Standard Care Group

Intervention Type PROCEDURE

Includes pharmacological treatment (e.g., NSAIDs, muscle relaxants) and physical therapy interventions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioral Therapy Group

Includes Cognitive Behavioral Therapy (CBT), relaxation techniques, and biofeedback.

Intervention Type BEHAVIORAL

Standard Care Group

Includes pharmacological treatment (e.g., NSAIDs, muscle relaxants) and physical therapy interventions

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18-65 years.
* Diagnosed with Temporomandibular Disorders (TMD) based on DC/TMD Axis I and Axis II criteria.
* Presenting with symptoms such as jaw pain, limited jaw movement, or psychosocial distress (anxiety, depression).
* Willing and able to provide informed consent.
* Able to comply with the study protocol and attend all follow-up visits.

Exclusion Criteria

* Severe systemic diseases or other neurological conditions that could interfere with treatment or outcomes.
* History of psychiatric disorders unrelated to TMD, such as schizophrenia or bipolar d disorder.
* Pregnant or lactating women.
* Use of medications or treatments within the past month that could influence study outcomes (e.g., corticosteroids, strong analgesics).
* Individuals with severe dental or maxillofacial conditions requiring immediate surgical intervention.
* Non-compliance with previous medical advice or treatment for TMD. Participants unable to understand or follow the study procedures due to language barriers or cognitive impairments.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Khalid University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sunil Kumar Vaddamanu

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

King Khalid University

Abhā, , Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ECM#2024-3196

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

iCBT for Cardiac Anxiety in Patients With NCCP
NCT06136494 ACTIVE_NOT_RECRUITING NA
Cognitive Behavioral Therapy (CBT) for Tinnitus
NCT00724152 COMPLETED PHASE1/PHASE2